Figure 2From: Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)- LLO immunotherapyAddition of anti-PD-1 Ab to Lm-LLO-E7 enhances therapeutic potency of treatment. A. Treatment schedule. B. Tumor volumes of individual mice for each treatment measured every 3–4 days. C. The Kaplan-Meier plot depicts overall survival. Similar results were obtained from three independent experiments.Back to article page